BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 37724299)

  • 1. Nano drug delivery systems improve metastatic breast cancer therapy.
    Zhu R; Lang T; Yin Q; Li Y
    Med Rev (2021); 2021 Dec; 1(2):244-274. PubMed ID: 37724299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Versatile biomimetic nanomedicine for treating cancer and inflammation disease.
    Zhao Z; Wang D; Li Y
    Med Rev (2021); 2023 Apr; 3(2):123-151. PubMed ID: 37724085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor therapy for breast cancer: Focus on tumor-associated macrophages and nanosized drug delivery systems.
    Zhan C; Jin Y; Xu X; Shao J; Jin C
    Cancer Med; 2023 May; 12(10):11049-11072. PubMed ID: 36794651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational Design of Nanotherapeutics Based on the Five Features Principle for Potent Elimination of Cancer Stem Cells.
    Zhang Z; Deng Q; Xiao C; Li Z; Yang X
    Acc Chem Res; 2022 Feb; 55(4):526-536. PubMed ID: 35077133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review.
    Khan MI; Hossain MI; Hossain MK; Rubel MHK; Hossain KM; Mahfuz AMUB; Anik MI
    ACS Appl Bio Mater; 2022 Mar; 5(3):971-1012. PubMed ID: 35226465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimuli-responsive and biomimetic delivery systems for sepsis and related complications.
    Ismail EA; Devnarain N; Govender T; Omolo CA
    J Control Release; 2022 Dec; 352():1048-1070. PubMed ID: 36372385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent progress in sono-photodynamic cancer therapy: From developed new sensitizers to nanotechnology-based efficacy-enhancing strategies.
    Zheng Y; Ye J; Li Z; Chen H; Gao Y
    Acta Pharm Sin B; 2021 Aug; 11(8):2197-2219. PubMed ID: 34522584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronic acid-based nano drug delivery systems for breast cancer treatment: Recent advances.
    Jia Y; Chen S; Wang C; Sun T; Yang L
    Front Bioeng Biotechnol; 2022; 10():990145. PubMed ID: 36091467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the Nano-Drug Delivery System in Treatment of Cardiovascular Diseases.
    Deng Y; Zhang X; Shen H; He Q; Wu Z; Liao W; Yuan M
    Front Bioeng Biotechnol; 2019; 7():489. PubMed ID: 32083068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies of overcoming the physiological barriers for tumor-targeted nano-sized drug delivery systems.
    Pi Y; Zhou J; Wang J; Zhong J; Zhang L; Wang Y; Yu L; Yan Z
    Curr Pharm Des; 2015; 21(42):6236-45. PubMed ID: 26503142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggregation-induced emission (AIE) fluorophores as imaging tools to trace the biological fate of nano-based drug delivery systems.
    Wang Y; Zhang Y; Wang J; Liang XJ
    Adv Drug Deliv Rev; 2019 Mar; 143():161-176. PubMed ID: 30529308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanomedicine and epigenetics: New alliances to increase the odds in pancreatic cancer survival.
    Urbanova M; Cihova M; Buocikova V; Slopovsky J; Dubovan P; Pindak D; Tomas M; García-Bermejo L; Rodríguez-Garrote M; Earl J; Kohl Y; Kataki A; Dusinska M; Sainz B; Smolkova B; Gabelova A
    Biomed Pharmacother; 2023 Sep; 165():115179. PubMed ID: 37481927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of
    Wang T; Zhang D; Sun D; Gu J
    J Pharm Anal; 2020 Jun; 10(3):221-232. PubMed ID: 32612868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational design of multimodal therapeutic nanosystems for effective inhibition of tumor growth and metastasis.
    Wang F; Huang Q; Wang Y; Zhang W; Lin R; Yu Y; Shen Y; Cui H; Guo S
    Acta Biomater; 2018 Sep; 77():240-254. PubMed ID: 30012354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Redox-sensitive nanoscale drug delivery systems for cancer treatment.
    Mirhadi E; Mashreghi M; Faal Maleki M; Alavizadeh SH; Arabi L; Badiee A; Jaafari MR
    Int J Pharm; 2020 Nov; 589():119882. PubMed ID: 32941986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the variations and biomedical applications of stimuli-responsive nanodrug delivery systems.
    Gong Z; Peng S; Cao J; Tan H; Zhao H; Bai J
    Nanotechnology; 2024 Jan; 35(13):. PubMed ID: 38198449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of nanoparticle drug delivery systems responsive to endogenous breast cancer microenvironment.
    Zou T; Lu W; Mezhuev Y; Lan M; Li L; Liu F; Cai T; Wu X; Cai Y
    Eur J Pharm Biopharm; 2021 Sep; 166():30-43. PubMed ID: 34098073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo targeting of metastatic breast cancer via tumor vasculature-specific nano-graphene oxide.
    Yang D; Feng L; Dougherty CA; Luker KE; Chen D; Cauble MA; Banaszak Holl MM; Luker GD; Ross BD; Liu Z; Hong H
    Biomaterials; 2016 Oct; 104():361-71. PubMed ID: 27490486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-sensitive nano-systems for drug delivery in cancer therapy.
    Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
    Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis.
    Gu X; Gao Y; Wang P; Wang L; Peng H; He Y; Liu Y; Feng N
    J Control Release; 2021 May; 333():374-390. PubMed ID: 33798666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.